| |
| |
|
| Insider
Information: |
Boulding Mark Elliott |
| Relationship: |
|
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
92,389 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,143,998 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
92,389 |
|
|
| Total
Value |
$3,143,998 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
11
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -198.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
92,389 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLOOfficer |
• – – |
2013-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,284 |
|
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2014-03-20 |
4 |
AS |
$30.96 |
$311,117 |
D/D |
(10,049) |
32,235 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2015-03-20 |
4 |
AS |
$67.77 |
$1,440,247 |
D/D |
(21,142) |
11,093 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec VP and CLO |
• – – |
2015-06-08 |
4 |
OE |
$10.85 |
$673,601 |
D/D |
62,083 |
73,176 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec VP and CLO |
• – – |
2015-06-08 |
4 |
AS |
$53.87 |
$3,128,737 |
D/D |
(56,849) |
16,327 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
27,034 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2019-06-28 |
4 |
AS |
$45.00 |
$3,490,875 |
D/D |
(77,575) |
29,524 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2019-06-28 |
4 |
OE |
$10.85 |
$880,723 |
D/D |
77,575 |
30,664 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2019-07-01 |
4 |
OE |
$10.85 |
$2,521,639 |
D/D |
104,092 |
47,024 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2019-07-01 |
4 |
AS |
$45.00 |
$4,684,140 |
D/D |
(104,092) |
29,524 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2019-07-05 |
4 |
OE |
$11.23 |
$231,279 |
D/D |
15,312 |
33,899 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2019-07-05 |
4 |
AS |
$44.45 |
$685,097 |
D/D |
(15,312) |
29,524 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
39,724 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2020-07-07 |
4 |
OE |
$11.23 |
$462,569 |
D/D |
30,625 |
57,224 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2020-07-07 |
4 |
AS |
$54.11 |
$1,688,037 |
D/D |
(30,625) |
39,724 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-01-05 |
4 |
S |
$62.37 |
$48,150 |
D/D |
(772) |
38,952 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,200 |
49,152 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-02-01 |
4 |
S |
$56.96 |
$44,312 |
D/D |
(778) |
48,374 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-07-08 |
4 |
AS |
$45.20 |
$352,968 |
D/D |
(7,805) |
48,374 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-07-08 |
4 |
OE |
$11.23 |
$127,008 |
D/D |
7,805 |
49,779 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-07-09 |
4 |
OE |
$18.01 |
$25,736 |
D/D |
1,429 |
48,618 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-07-09 |
4 |
AS |
$45.00 |
$64,306 |
D/D |
(1,429) |
48,374 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-09-02 |
4 |
OE |
$18.01 |
$60,568 |
D/D |
3,363 |
51,737 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2021-09-02 |
4 |
AS |
$45.01 |
$151,375 |
D/D |
(3,363) |
48,374 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Exec. VP and CLO |
• – – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
61,889 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
